Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J. R. Kalden

Showing results (1-10 of 480) with videos related to

Pageof 48
Sort By:
Clinical and Experimental Rheumatology|September 1, 1992
WHO/IUIS Standardization ProgrammeJ R Kalden
Agents and Actions. Supplements|January 1, 1982
Inflammation: crucial areas and clinical relevanceJ R Kalden
Immunitat Und Infektion|July 1, 1975
[Auto-immune diseases of the skeletal muscle-system. Immune-pathogenetic mechanisms in myasthenia gravis and polymyositis (author's transl)]J R Kalden
Israel Journal of Medical Sciences|January 1, 1996
Pathogenic aspects of systemic lupus erythematosusJ R Kalden
Current Opinion in Rheumatology|May 1, 1994
Biologic agents in the therapy of inflammatory rheumatic diseases, including therapeutic antibodies, cytokines, and cytokine antagonistsJ R Kalden
Rheumatology (Oxford, England)|June 21, 2003
IntroductionJ. R. Kalden
MMW, Munchener Medizinische Wochenschrift|April 28, 1978
[LE diagnosis made easy]J R Kalden
Zeitschrift Fur Immunitatsforschung, Allergie Und Klinische Immunologie|May 1, 1970
[Thymus pathology in diseases with disturbed immune reactions (review)]J R Kalden
The Israel Medical Association Journal : IMAJ|May 10, 2001
The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseasesJ R Kalden
Onkologie|August 1, 1987
[Cytokines in tumor therapy]J R Kalden
Pageof 48

Showing results (1-10 of 480) with videos related to

Sort By:
Pageof 48
Clinical and Experimental Rheumatology|September 1, 1992
WHO/IUIS Standardization ProgrammeJ R Kalden
Agents and Actions. Supplements|January 1, 1982
Inflammation: crucial areas and clinical relevanceJ R Kalden
Immunitat Und Infektion|July 1, 1975
[Auto-immune diseases of the skeletal muscle-system. Immune-pathogenetic mechanisms in myasthenia gravis and polymyositis (author's transl)]J R Kalden
Israel Journal of Medical Sciences|January 1, 1996
Pathogenic aspects of systemic lupus erythematosusJ R Kalden
Current Opinion in Rheumatology|May 1, 1994
Biologic agents in the therapy of inflammatory rheumatic diseases, including therapeutic antibodies, cytokines, and cytokine antagonistsJ R Kalden
Rheumatology (Oxford, England)|June 21, 2003
IntroductionJ. R. Kalden
MMW, Munchener Medizinische Wochenschrift|April 28, 1978
[LE diagnosis made easy]J R Kalden
Zeitschrift Fur Immunitatsforschung, Allergie Und Klinische Immunologie|May 1, 1970
[Thymus pathology in diseases with disturbed immune reactions (review)]J R Kalden
The Israel Medical Association Journal : IMAJ|May 10, 2001
The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseasesJ R Kalden
Onkologie|August 1, 1987
[Cytokines in tumor therapy]J R Kalden
Pageof 48